Jazz Pharmaceuticals plc (JAZZ)

NASDAQ: JAZZ · Real-Time Price · USD

Compare

137.32

-0.26 (-0.19%)

At close: Oct 7, 2025, 4:00 PM EDT

135.90

-1.42 (-1.03%)

After-hours: Oct 7, 2025, 5:07 PM EDT

Jazz Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Revenue	4,087	4,069	3,834	3,659	3,094	2,364	Upgrade
Revenue Growth (YoY)	4.52%	6.12%	4.78%	18.26%	30.91%	9.34%	Upgrade
Cost of Revenue	321.4	310.7	284.13	267.13	217.68	148.92	Upgrade
Gross Profit	3,765	3,758	3,550	3,392	2,877	2,215	Upgrade
Selling, General & Admin	1,426	1,416	1,307	1,399	1,399	879.85	Upgrade
Research & Development	780.6	853.56	823.89	555.41	476.33	309.76	Upgrade
Operating Expenses	2,839	2,897	2,739	2,553	2,401	1,449	Upgrade
Operating Income	925.88	861.64	810.73	839.14	475.26	765.46	Upgrade
Interest Expense	-315.53	-344.4	-354.54	-299.74	-280.57	-110.81	Upgrade
Interest & Investment Income	104.5	106.3	65.1	11.5	1.8	11.1	Upgrade
Earnings From Equity Investments	-0.93	-1.66	-3.01	-9.92	-0.71	-2.96	Upgrade
Currency Exchange Gain (Loss)	-9.01	-8.18	8.79	-19.01	-4.35	-3.27	Upgrade
EBT Excluding Unusual Items	704.91	613.71	527.07	521.97	191.43	659.52	Upgrade
Merger & Restructuring Charges	-139.82	-135.01	-151.45	-326.88	-304.99	-	Upgrade
Asset Writedown	-	-	-61.7	-133.65	-	-136.14	Upgrade
Legal Settlements	-172	-	-	-	-	-	Upgrade
Pretax Income	-512.27	468.69	294.92	-382.71	-113.55	272.13	Upgrade
Income Tax Expense	-107.43	-91.43	-119.91	-158.65	216.12	33.52	Upgrade
Earnings From Continuing Operations	-404.84	560.12	414.83	-224.06	-329.67	238.62	Upgrade
Net Income	-404.84	560.12	414.83	-224.06	-329.67	238.62	Upgrade
Net Income to Common	-404.84	560.12	414.83	-224.06	-329.67	238.62	Upgrade
Net Income Growth	-	35.02%	-	-	-	-54.41%	Upgrade
Shares Outstanding (Basic)	61	62	63	63	60	56	Upgrade
Shares Outstanding (Diluted)	61	66	72	63	60	57	Upgrade
Shares Change (YoY)	-12.92%	-8.41%	15.23%	4.77%	5.62%	-1.80%	Upgrade
EPS (Basic)	-6.63	9.06	6.55	-3.58	-5.52	4.28	Upgrade
EPS (Diluted)	-6.63	8.65	6.10	-3.58	-5.52	4.22	Upgrade
EPS Growth	-	41.75%	-	-	-	-53.57%	Upgrade
Free Cash Flow	1,265	1,358	1,068	1,243	750.87	884.64	Upgrade
Free Cash Flow Per Share	20.73	20.57	14.82	19.87	12.58	15.65	Upgrade
Gross Margin	92.14%	92.36%	92.59%	92.70%	92.97%	93.70%	Upgrade
Operating Margin	22.66%	21.18%	21.14%	22.93%	15.36%	32.39%	Upgrade
Profit Margin	-9.91%	13.77%	10.82%	-6.12%	-10.65%	10.10%	Upgrade
Free Cash Flow Margin	30.95%	33.37%	27.86%	33.97%	24.27%	37.43%	Upgrade
EBITDA	1,598	1,522	1,449	1,469	1,028	1,044	Upgrade
EBITDA Margin	39.11%	37.40%	37.80%	40.13%	33.22%	44.16%	Upgrade
D&A For EBITDA	672.53	660.07	638.7	629.47	552.48	278.25	Upgrade
EBIT	925.88	861.64	810.73	839.14	475.26	765.46	Upgrade
EBIT Margin	22.66%	21.18%	21.14%	22.93%	15.36%	32.39%	Upgrade
Effective Tax Rate	-	-	-	-	-	12.32%	Upgrade
Revenue as Reported	4,087	4,069	3,834	3,659	3,094	2,364	Upgrade
Advertising Expenses	-	107.4	92.2	108.8	161.5	99.6	Upgrade

Updated Aug 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q